If you need more lookups,
subscriptions start at $34 USD/month.
Alexandra Steinberg Location
South San Francisco, CA, US
Alexandra Steinberg Work
Senior Medical Director @ (July 2024 - Present)
Senior Medical Director @ (March 2023 - July 2024)
Senior Medical Director @ (April 2021 - March 2023)
Senior Medical Director @ (February 2020 - April 2021)
Medical Director @ (July 2014 - February 2020)
Associate Director, Medical Monitor; Clinical Sciences @ Cerexa (July 2012 - June 2014)
Clinical Trial Coordinator @ San Francisco Clinical Research Center (March 2012 - June 2012)
Clinical Trial Coordinator, Volunteer @ (December 2011 - February 2012)
Volunteer @ (November 2010 - December 2011)
Post-graduate MD and PhD Thesis research @ Saratov State Medical University (September 2006 - January 2009)
Resident @ Saratov State Medical University (January 2004 - January 2006)
Alexandra Steinberg Education
UCSC-extension Silicon Valley
Clinical Trial and Management Certificate (Clinical Trial)
2011-2012
Saratov State Medical University
MD (PhD, Pediatrics)
1998-2009
Alexandra Steinberg Skills
Orphan Drugs
Medical Affairs
Medical Monitoring
Hepatology
Clinical Research
Clinical Trials
Infectious Diseases
Clinical Development
GCP
Pharmaceutical Industry
Drug Development
Healthcare
Pediatrics
Biotechnology
Medicine
Research
Lifesciences
Therapeutic Areas
Data Analysis
Hospitals
Alexandra Steinberg Summary
Alexandra Steinberg, based in South San Francisco, CA, US, is currently a Senior Medical Director at Genentech. Alexandra Steinberg brings experience from previous roles at Carmot Therapeutics, Inc., Axcella and CymaBay Therapeutics. Alexandra Steinberg holds a 2011 - 2012 Clinical Trial and Management Certificate in Clinical Trial @ UCSC-extension Silicon Valley. With a robust skill set that includes Orphan Drugs, Medical Affairs, Medical Monitoring, Hepatology, Clinical Research and more. Alexandra Steinberg has 1 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Alexandra Steinberg?
Find contact details for 700 million professionals.